Highest-materiality recent filing
Clarus Q2 net income $4.7M vs loss; Outdoor sales up 8.5%; guides FY adj EBITDA $12-13M
Sales $56.2M (+1.6% YoY); Outdoor segment +8.5% to $39.8M, Adventure -11.9% to $16.4M.
Sales of $61.9M (+2.5% YoY); gross margin 36.8% (+240 bps); net loss $(0.09)/share vs $(0.14).
Clarus Q4 sales $65.4M, net loss $0.81/share; FY2026 guidance implies recovery
Q4 sales $65.4M (down 8% YoY); net loss $31.3M ($0.81 loss per diluted share) includes $29.9M goodwill impairment.
Clarus Q3 sales up 3% to $69.3M; net loss narrows, adjusted EBITDA rises 15%
Sales $69.3M (+3% YoY); Outdoor -1% to $48.7M, Adventure +16% to $20.7M.
Clarus Q2 net loss widens to $8.4M; sells PIEPS brand for $9.1M
Sales $55.2M, down 2% YoY; Outdoor +1% to $36.7M, Adventure -8% to $18.6M.
Clarus board allows Kanders to increase stake to 32.9%; two directors depart
Kanders (Executive Chairman) can acquire up to 5,940,700 additional shares, raising beneficial ownership from ~17.9% to 32.9% within 24 months.
Q1 sales $60.4M, down 13% YoY; net loss $(0.14) per diluted share; adjusted EBITDA margin (1.3)%.
Clarus Q4 net loss $65.5M; sales down 6.7% to $71.4M; provides FY2025 outlook
Q4 net loss $65.5M ($1.71/diluted share) vs loss of $8.4M ($0.22) YoY; includes $44.8M goodwill impairment and $21M tax valuation allowance.
Clarus and Black Diamond receive grand jury subpoenas from U.S. Attorney over avalanche transmitters
Clarus and subsidiary Black Diamond Equipment received grand jury subpoenas in January 2025 from the U.S. Attorney’s Office for the District of Utah.
Clarus Q3 sales fall 17.5% to $67.1M; lowers FY2024 adjusted EBITDA guidance to ~$8M midpoint
Sales $67.1M, down from $81.3M YoY; net loss $3.2M ($0.08/share) vs loss $1.3M ($0.03/share).
Clarus Q2 sales fall 2% to $56.5M, net loss $5.5M; cuts EBITDA guidance, reviews PIEPS
Q2 sales $56.5M (-2% YoY); net loss $5.5M ($0.14) vs $2.1M loss ($0.06) prior year.
Clarus Q1 loss from continuing ops widens to $6.5M; Adventure sales up 27%
Sales $69.3M vs $70.3M YoY; gross margin 35.9% (adj. 36.9%).
Clarus posts $15.8M full-year continuing ops loss in 2023; sells Precision Sport for $175M
Sale of Precision Sport segment closed Feb 29, 2024 for $175M; expected gain in Q1 2024.
Clarus permits Greenhouse and Kanders to increase stakes to 15% and 26.7% under poison pill waiver
Greenhouse (current ~11.9% owner) approved to acquire up to 15.0% of CLAR common stock within 12 months.
Q4 2023 sales $76.5M (+4% YoY); gross margin 28.9% vs 37.2%; adjusted EBITDA -$3.5M vs +$3.6M; adjusted EPS -$0.07 vs +$0.11.
Clarus closes $175M sale of Precision Sport segment to JDH Capital; pays off all debt
Sale of Sierra Bullets & Barnes Bullets for $175M cash (before ~$742 working capital adjustment) closed Feb 29, 2024.
Clarus to sell Precision Sport segment for $175M cash; expects close in Q1 2024
Agreement to sell Sierra Bullets and Barnes Bullets to Bullseye Acquisitions, an affiliate of JDH Capital Co.
Clarus Q3 sales down 13% to $100.1M; net loss of $1.3M; FY2023 guidance lowered
Sales $100.1M (-13.5% YoY); gross margin 35.5% (+140 bps).
Clarus receives $160M non-binding offer from Exec Chairman to buy Precision Sport segment
Warren B. Kanders offers $160M (cash-free, debt-free) to acquire Precision Sport segment via affiliated entity.
Clarus Q2 sales down 27% to $83.7M; net loss of $2.1M; lowers FY2023 guidance
Sales $83.7M (down 27% YoY); net loss $2.1M vs income $3.8M; adj. EPS $0.11 vs $0.33 YoY.
Clarus Q1 2023 sales down 14% YoY to $97.4M; adj. EPS $0.18 vs $0.37
Net income $1.6M ($0.04 diluted EPS) vs $5.3M ($0.13) a year ago.
Clarus Corp. President John Walbrecht departs; role not filled
Mutual termination effective March 31, 2023; company will not fill President role.
Base salary $600,000/year; minimum cash bonus equal to 100% of base upon achieving target EBITDA.
Clarus reports Q4 net loss of $81.6M on $104.2M sales; 2023 sales guidance ~$420M
Q4 sales $104.2M vs $118.2M YoY; net loss $81.6M ($2.20 loss per share) includes $92.3M non-cash impairment in Adventure segment.
Clarus Q3 net income drops 38% to $2.8M; cuts FY22 EBITDA guidance to $64M from $78M
Q3 sales $115.7M (+6% YoY, +9% constant currency); net income $2.8M ($0.07 diluted) vs $4.5M ($0.13) YoY.
Clarus Q2 2022 sales up 57% to $114.9M; record adj. EBITDA $17.6M; new $50M buyback
Record Q2 sales $114.9M (+57% YoY); net income $3.8M ($0.09) up 105%; adjusted EPS $0.33 (up 92%).
GAAP net income $5.3M ($0.13 diluted EPS) vs $5.7M ($0.17) prior year; adjusted net income $14.8M ($0.37) up 44%.
Clarus amends credit facility: $300M revolver, $125M term loan, maturity April 2027
New $300M secured revolving credit facility and $125M term loan fully drawn on April 18, 2022.
Clarus Q4 2021 sales $118.2M record; net income $0.36 EPS; 2022 guidance $470M sales
Q4 2021 sales $118.2M (+56% YoY); adjusted EBITDA record $20.0M (16.9% margin).
Clarus appoints Michael Yates as CFO; Aaron Kuehne becomes COO
Michael Yates appointed CFO effective Jan 3, 2022; previously corporate controller and interim CFO at IDEX Corporation.
Clarus Q3 sales record $109M (+69% YoY), raised FY21 guidance: sales $362.5M, adj EBITDA $57M
Q3 sales record $109.0M (+69% YoY); adjusted gross margin 38.8% (+520 bps); adj EBITDA $19.2M record (+111%).
Underwriting agreement for 2,750,000 shares at $27.00/share; net proceeds ~$69.8M after 6% underwriting discount.
Clarus reports preliminary Q3 sales $107-108M, raises FY2021 outlook
Preliminary Q3 2021 sales $107-108M, up 66-67% YoY; adjusted EBITDA $18.5-18.8M, up ~103-106%.
Clarus Corporation’s (the “Company”) Board of Directors appointed Mr. Roger Werner to serve on the Company’s Board of Directors effective as of March 8, 2024, until the Company’s next Annual Meeting of Stockholders and until his successor is duly elected and qualified.
On January 8, 2024, James E. Walker III notified the Board of Directors of Clarus Corporation (the “Company”) of his resignation as a director of the Company, effective as of January 8, 2024.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (b) The disclosure set forth in Item 1.01 of this Report with respect to Mr. Kuehne is incorporated into this Item 5.02 by reference.
The disclosure set forth in Item 1.02 of this Report with respect to Mr. Walbrecht is incorporated into this Item 5.02 by reference. The Company does not anticipate filling the role of President of the Company at this time.
On February 1, 2022, Clarus Corporation (the “Company”) appointed Mr. James E. Walker III to serve on the Company’s Board of Directors until the Company’s next Annual Meeting of Stockholders and until his successor is duly elected and qualified.
Mr. Michael J. Yates was appointed to serve as the Company’s new Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective as of January 3, 2022.
As a result of the promotion of Aaron J. Kuehne to the new roles of Executive Vice President and Chief Operating Officer, effective as of January 3, 2022, Mr. Kuehne ceased serving as the Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Max materiality 0.85 · Median 0.65 · Most common event earnings